J. B. Chemicals & Pharmaceuticals Salute del bilancio
Salute finanziaria criteri di controllo 6/6
J. B. Chemicals & Pharmaceuticals ha un patrimonio netto totale di ₹32.1B e un debito totale di ₹816.4M, che porta il suo rapporto debito/patrimonio netto a 2.5%. Le sue attività totali e le sue passività totali sono rispettivamente ₹40.3B e ₹8.2B. L'EBIT di J. B. Chemicals & Pharmaceuticals è ₹8.1B rendendo il suo rapporto di copertura degli interessi 33.1. Ha liquidità e investimenti a breve termine pari a ₹4.2B.
Informazioni chiave
2.5%
Rapporto debito/patrimonio netto
₹816.40m
Debito
| Indice di copertura degli interessi | 33.1x |
| Contanti | ₹4.17b |
| Patrimonio netto | ₹32.12b |
| Totale passività | ₹8.17b |
| Totale attività | ₹40.29b |
Aggiornamenti recenti sulla salute finanziaria
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29Recent updates
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Nov 09J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price
Sep 24Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( ₹19.1B ) di JBCHEPHARM superano le sue passività a breve termine ( ₹6.2B ).
Passività a lungo termine: Le attività a breve termine di JBCHEPHARM ( ₹19.1B ) superano le sue passività a lungo termine ( ₹2.0B ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: JBCHEPHARM ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di JBCHEPHARM si è ridotto da 3% a 2.5% negli ultimi 5 anni.
Copertura del debito: Il debito di JBCHEPHARM è ben coperto dal flusso di cassa operativo ( 912.6% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di JBCHEPHARM sono ben coperti dall'EBIT ( 33.1 x copertura).